http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-543762-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5a71f37502fcf3906a8f2b9232a3556 |
filingDate | 2003-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9999053a80c9d0c589034abf62ed2618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_118c9f5bd97a64db2b1aa2ff9c63960f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc35642a18e4ca8d5a9cbaa25faa053b |
publicationDate | 2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-543762-A |
titleOfInvention | Use of an alpha2delta subunit calcium channel modulator such as gabapentin or pregabalin in a medicament for treating non-painful disorders of the bladder |
abstract | Use of a GABA analog that is an alpha2delta subunit calcium channel modulator in the manufacture of a medicament for treating urinary frequency, urinary urgency, nocturia, OAB dry or detrusor instability. |
priorityDate | 2003-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.